** Medical device maker Intuitive Surgical's ISRG.O shares up 3% at $492.79 after Q1 results beat
** Co posts adj. EPS of $1.81, beating analysts' estimates of $1.72 - as per data compiled by LSEG
** Reports Q1 revenue of $2.25 bln versus estimates of $2.19 bln
** ISRG projects 2025 adj. gross profit margin in a range of 65% to 66.5% of revenue, lower than last year's 69.1% due to tariffs
** Co says U.S. tariffs to weigh on its business for the rest of the year
** At least 12 brokerages cut target price on stock, citing tariffs; J.P. Morgan cuts PT to $605 from $675
** Piper Sandler lowers PT to $575 from $670; cites tariff-related lowered gross profit margin guidance
** "While the tariff-related GM guide-down is a touch disappointing - we believe this headwind will be transitory and that ISRG has essentially built-in a 'worst case' scenario," -brokerage
** 21 out of 33 brokerages rate stock "buy" or higher, 12 "hold"; Median PT is $607.45 - data compiled by LSEG
** Including current move, ISRG down 5.6% YTD
(Reporting by Twesha Dikshit)
((Twesha.Dikshit@thomsonreuters.com))
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。